The results showed that high-intensity IL-23 clustered in the vessels, surrounding small lymph nodes, the edges of tumors, and areas infiltrated by cancer cells in the tumor tissues (Fig. 1a and Supplementary Fig. 1). Here, IL37 is linked to neoplasm.